Deferoxamine

Revision as of 21:50, 8 September 2018 by Jonwarren (talk | contribs) (Updated links and information for pharmacology/side effects)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

General

  • Type: Antidote
  • Dosage Forms:
  • Routes of Administration: IV, IM
  • Common Trade Names: Desferal

Adult Dosing

Iron toxicity

  • 1000mg IV; start at 5mg/kg/hr, increase up to 15mg/kg/hr as tolerated for up to 24hrs
  • Subsequent doses are 500mg increments guided by clinical status of patient / urine color
  • Recommended amount during first 24hr is 360mg/kg not to exceed 6g.

Pediatric Dosing

Iron toxicity

  • 15 mg/kg/h IV
  • Prolonged use >24-48 hours may increase risk of ARDS
  • 100mg deferoxamine chelates 9mg free iron

Special Populations

  • Pregnancy Rating:
  • Lactation risk:
  • Renal Dosing
    • Adult: Contraindicated in severe impairment or anuria.
    • Pediatric: Contraindicated in severe impairment or anuria
  • Hepatic Dosing
    • Adult: Not defined
    • Pediatric: Not defined

Indications

  • Systemic toxicity and iron level > 350 mcg/dL
  • Metabolic acidosis
  • Progressive symptoms
  • Serum iron level >500 mcg/dL

Contraindications

  • Allergy to class/drug
  • Renal failure patients not on hemodialysis

Adverse Reactions

Pharmacology

  • Half-life: 6h
  • Metabolism: Plasma
  • Excretion: Urine, bile/feces
  • Mechanism of Action:

Comments

  • Chelates iron and creates a water-soluble compound ferrioxamine that is renally excreted and can be dialyzed.[2]

See Also

References

  1. Mazzoleni G. et al. Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy. Dig Dis Sci 1991; 36:1154-1160.
  2. Cite error: Invalid <ref> tag; no text was provided for refs named ironoverview